Deoxyglucose
Showing 26 - 50 of 190
Endometriosis Trial in Saint-Denis, Saint-Pierre (PET scanner with injection of 18 FDG (18F-2-fluoro-2-deoxy-D-glucose)
Not yet recruiting
- Endometriosis
- PET scanner with injection of 18 FDG (18F-2-fluoro-2-deoxy-D-glucose) (radiolabel)
-
Saint-Denis, France
- +1 more
Mar 1, 2022
Brain Glioblastoma Trial in Houston (Computed Tomography, Fludeoxyglucose F-18, Magnetic Resonance Imaging)
Completed
- Brain Glioblastoma
- Computed Tomography
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
Breast Cancer Trial in Salt Lake City ([18F]Flutemetamol, [18F]fluoro-2-deoxy-D-glucose (FDG), Functional Magnetic Resonance
Recruiting
- Breast Cancer
- [18F]Flutemetamol
- +2 more
-
Salt Lake City, UtahHuntsman Cancer Institute
Feb 3, 2022
MRI and PET Imaging in Predicting Treatment Response in Stage
Active, not recruiting
- Cervical Adenocarcinoma
- +12 more
- Computed Tomography
- +5 more
-
Miami, Florida
- +5 more
Oct 4, 2022
Cigarette Smoker, Current Smoker, Former Smoker Trial in Palo Alto (Computed Tomography, Fludeoxyglucose F-18, Fluorine F 18
Recruiting
- Cigarette Smoker
- +4 more
- Computed Tomography
- +3 more
-
Palo Alto, CaliforniaStanford Cancer Institute Palo Alto
Jun 16, 2022
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma Trial (drug,
Not yet recruiting
- Anatomic Stage II Breast Cancer AJCC v8
- +3 more
- Chemotherapy
- +4 more
- (no location specified)
Jan 24, 2023
Alzheimer's Disease Trial in Colombia (Crenezumab, Placebo)
Active, not recruiting
- Alzheimer's Disease
- Crenezumab
- Placebo
-
Armenia, Colombia
- +3 more
Nov 21, 2022
Recurrent DLBCL, Refractory DLBCL Trial in Houston (Chemotherapy, Computed Tomography, Fludeoxyglucose F-18)
Completed
- Recurrent Diffuse Large B-Cell Lymphoma
- Refractory Diffuse Large B-Cell Lymphoma
- Chemotherapy
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 27, 2022
Brain Cancer Trial in Salt Lake City ([18F]fluoro-2-deoxy-D-glucose (FDG),
Recruiting
- Brain Cancer
- [18F]fluoro-2-deoxy-D-glucose (FDG)
- +3 more
-
Salt Lake City, UtahHuntsman Cancer Institute
Jan 3, 2023
Diagnosis and Clinical Management of Angiogenic Breast Cancer Trial in Chandigarh, New Delhi, Johannesburg (Ga-68-PEG-?vß3-IAC
Not yet recruiting
- Diagnosis and Clinical Management of Angiogenic Breast Cancer
- Ga-68-PEG-Αvβ3-IAC PET/CT
-
Chandigarh, India
- +2 more
May 27, 2022
Glioblastoma Trial in Los Angeles (Computed Tomography, Fludeoxyglucose F-18, Positron Emission Tomography)
Recruiting
- Glioblastoma
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Feb 2, 2022
Breast Carcinoma, Fallopian Tube Carcinoma, Ovarian Carcinoma Trial in Houston (Computed Tomography, Fludeoxyglucose F-18,
Recruiting
- Breast Carcinoma
- +7 more
- Computed Tomography
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Aug 24, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Seattle
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Biopsy
- +9 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Nov 17, 2023
Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Los Angeles (procedure, drug, other)
Not yet recruiting
- Recurrent Multiple Myeloma
- Refractory Multiple Myeloma
- Bone Marrow Aspiration
- +10 more
-
Los Angeles, CaliforniaMelanie Ayala Ceja
Jul 10, 2023
Breast Cancer Trial (MRI + PEM image)
Terminated
- Breast Cancer
- MRI + PEM image
- (no location specified)
Oct 5, 2021
Stage IIB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Non-Small Cell
Active, not recruiting
- Stage IIB Lung Non-Small Cell Carcinoma AJCC v7
- +2 more
- Computed Tomography
- +7 more
-
Seattle, Washington
- +1 more
Jul 18, 2022
Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Nashville (procedure, drug, other, biological, radiation)
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- Stage IV Lung Cancer AJCC v8
- Biospecimen Collection
- +9 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Aug 11, 2022
Positron Emission Tomography in Detecting Primary Tumor in Cases
Recruiting
- Metastasis of Unknown Origin
- PET/CT
-
Sohag, EgyptSohag university Hospital
Oct 11, 2023
Stage I Lung Cancer, Stage I NSCLC AJCC v7, Stage IA Non-Small Cell Lung Carcinoma AJCC v7 Trial in Atlanta (drug, procedure,
Active, not recruiting
- Stage I Lung Cancer
- +7 more
- Fludeoxyglucose F-18
- +2 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Mar 2, 2022
Retinal and Cognitive Dysfunction in Type 2 Diabetes
Active, not recruiting
- Retinal Function
- +2 more
-
Barcelona, SpainRafael Simó
Aug 30, 2022
Immune Checkpoint Inhibitor-Related Myocarditis
Recruiting
- Myocarditis Acute
- Computed Tomography
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Sep 21, 2021
Metastatic Malignant Tumor in the Brain, Metastatic Malignant Solid Tumor Trial in Houston (Fludeoxyglucose F-18, Magnetic
Recruiting
- Metastatic Malignant Neoplasm in the Brain
- Metastatic Malignant Solid Neoplasm
- Fludeoxyglucose F-18
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 14, 2021
Nodular Lymphocyte Predominant Hodgkin Lymphoma, Recurrent Nodular Lymphocyte Predominant Hodgkin Lymphoma, Refractory Nodular
Not yet recruiting
- Nodular Lymphocyte Predominant Hodgkin Lymphoma
- +2 more
- Biopsy
- +9 more
- (no location specified)
Jun 1, 2023
Type 2 Diabetes, Cardiovascular Risk Factor Trial in Catanzaro (Empagliflozin 10 MG, Glimepiride 2 mg)
Completed
- Type 2 Diabetes
- Cardiovascular Risk Factor
- Empagliflozin 10 MG
- Glimepiride 2 mg
-
Catanzaro, ItalyUniversital Hospital Mater Domini
Jan 14, 2023
Lung Carcinoma, Solitary Pulmonary Nodule, Cigarette Smoking Behavior Trial in Nashville (procedure, radiation, drug, other)
Completed
- Lung Carcinoma
- +2 more
- Computed Tomography
- +5 more
-
Nashville, Tennessee
- +1 more
Oct 17, 2022